Intuitive Surgical (Nasdaq: ISRG) today reported its second quarter financial results for the period ended June 30, 2021. GAAP net income for
Key highlights from Intuitive Surgical (ISRG) Q2 2021 earnings results
Categories
Health Care
Absci IPO: Here’s all you need to know about bioengineering firm’s Nasdaq listing
Wall Street is probably going through the busiest phase since the recession, in terms of the number of businesses seeking to go
UnitedHealth Group Incorporated (UNH) Q2 2021 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q2 2021 earnings call dated Jul. 15, 2021 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- President and
US healthcare industry: Surviving the pandemic
The incessant spread of COVID-19 has taken a heavy toll on the healthcare industry in the US. Be it the need to
Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2021 earnings call dated Jul. 13, 2021 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
IPO News: Here’s what to know when Sera Prognostics goes public this week
The healthcare industry continues to grow at a rapid pace with diagnostic services playing an important role in this space. Women’s health
IPO News: Should you invest in Sight Sciences’ initial public offering?
The continuing stock market rally, at a time when the pandemic-hit economy is struggling to regain strength, has set off an IPO
Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2021 earnings call dated Jun. 29, 2021 Corporate Participants: Tim Brons -- Executive Vice President, Vida Strategic Partners,
Aerovate Therapeutics IPO: What awaits the biotech firm after market debut?
The IPO market has continued the bull run so far this year, unfazed by the virus-related uncertainties, with the technology and pharma
Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why
For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was a busy
Rite Aid Corporation (RAD) Q1 2022 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q1 2022 earnings call dated Jun. 24, 2021 Corporate Participants: Trent Kruse -- Senior Vice President, Investor Relations and
Context Therapeutics: Another clinical-stage oncology research firm to go public soon
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first
Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development
Patterson Companies, Inc. (PDCO) Q4 2021 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q4 2021 earnings call dated Jun. 23, 2021 Corporate Participants: John M. Wright -- Vice President, Investor Relations Mark
IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a
IPO News: What to look for when Elevation Oncology makes its Wall Street debut
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly
Trxade Health Inc. (NASDAQ: MEDS) Q2 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare services at
BeyondSpring, Inc.(BYSI) Q1 2021 Earnings Call Transcript
BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson -- Media & Investor Relations of LifeSci
Is Merck (MRK) stock still a buy after losing the vaccine race?
After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the mass production
LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?
For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges posed by
HealthEquity Inc (HQY) Q1 2022 Earnings Call Transcript
HealthEquity Inc (NASDAQ:HQY) Q1 2022 earnings call dated Jun. 07, 2021. Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President and Chief Executive Officer